These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2748945)

  • 21. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
    Zheng H; Olive PL
    Cancer Res; 1996 Jun; 56(12):2801-8. PubMed ID: 8665517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft.
    Joschko MA; Webster LK; Bishop JF; Groves J; Yuen K; Olver IN; Narayan KN; Ball DL
    Cancer Chemother Pharmacol; 1997; 40(6):534-9. PubMed ID: 9332470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
    Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitization by cisplatin of RIF1 tumour cells in vitro.
    Begg AC; van der Kolk PJ; Dewit L; Bartelink H
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Nov; 50(5):871-84. PubMed ID: 3490450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining the non-homologous repair process following cisplatin and radiation treatments.
    Myint WK; Ng C; Raaphorst GP
    Int J Radiat Biol; 2002 May; 78(5):417-24. PubMed ID: 12020431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog.
    Huang G; Wang H; Yang LX
    Anticancer Res; 2010 Mar; 30(3):937-44. PubMed ID: 20393017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).
    Reddy EK
    Br J Cancer Suppl; 1978 Jun; 3():250-4. PubMed ID: 277241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
    Sheldon PW; Hill SA; Foster JL; Fowler JF
    Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-modification of DNA repair and ionizing radiation lethality in yeast, Saccharomyces cerevisiae.
    Dolling JA; Boreham DR; Brown DL; Raaphorst GP; Mitchel RE
    Mutat Res; 1999 Mar; 433(2):127-36. PubMed ID: 10102039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of response to cisplatin, radiation and combined treatment for cells deficient in recombination repair pathways.
    Raaphorst GP; Leblanc M; Li LF
    Anticancer Res; 2005; 25(1A):53-8. PubMed ID: 15816518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839).
    Friedmann B; Caplin M; Hartley JA; Hochhauser D
    Clin Cancer Res; 2004 Oct; 10(19):6476-86. PubMed ID: 15475435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin.
    Dempke W; Voigt W; Grothey A; Schmoll HJ
    Anticancer Drugs; 1999 Jul; 10(6):545-9. PubMed ID: 10885902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.
    Eichholtz-Wirth H; Hietel B
    Br J Cancer; 1994 Oct; 70(4):579-84. PubMed ID: 7522509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
    Raaphorst GP; Miao J; Stewart D; Ng CE
    Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of radiation-induced cisplatin resistance in murine fibrosarcoma cells by selective modulation of the cyclic GMP-dependent transduction pathway.
    Eichholtz-Wirth H
    Br J Cancer; 1995 Aug; 72(2):287-92. PubMed ID: 7640207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
    Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
    Begg AC; Hofland I; Kummermehr J
    Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of combined modality therapy with cisplatin and radiation using intratumoral drug administration in murine tumors.
    Begg AC; Deurloo MJ; Kop W; Bartelink H
    Radiother Oncol; 1994 May; 31(2):129-37. PubMed ID: 8066192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery from sublethal damage by acutely hypoxic tumour cells in vivo and in vitro.
    McNally NJ; George KC; de Ronde J
    Br J Radiol; 1979 Aug; 52(620):642-9. PubMed ID: 486894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation damage repair capacity of a human germ-cell tumour cell line: inhibition by 3-aminobenzamide.
    Kelland LR; Burgess L; Steel GG
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Feb; 51(2):227-41. PubMed ID: 3104222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.